| Home | E-Submission | Sitemap | Editorial Office |  
top_img
Most Cited Articles > Browse Articles > Most Cited Articles




(2017~2021)

  • Most-cited are based on citations from 2019 ~ 2021.
  • 417 Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2016
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2019;51(2):417-430.   Published online March 18, 2019    DOI: https://doi.org/10.4143/crt.2019.138
                                     Cited By 191
    335 Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2017
    Seri Hong, Young-Joo Won, Young Ran Park, Kyu-Won Jung, Hyun-Joo Kong, Eun Sook Lee, The Community of Population-Based Regional Cancer Registries
    Cancer Res Treat. 2020;52(2):335-350.   Published online March 16, 2020    DOI: https://doi.org/10.4143/crt.2020.206
                                     Cited By 124
    431 Prediction of Cancer Incidence and Mortality in Korea, 2019
    Kyu-Won Jung, Young-Joo Won, Hyun-Joo Kong, Eun Sook Lee
    Cancer Res Treat. 2019;51(2):431-437.   Published online March 18, 2019    DOI: https://doi.org/10.4143/crt.2019.139
                                     Cited By 69
    351 Prediction of Cancer Incidence and Mortality in Korea, 2020
    Kyu-Won Jung, Young-Joo Won, Seri Hong, Hyun-Joo Kong, Eun Sook Lee
    Cancer Res Treat. 2020;52(2):351-358.   Published online March 16, 2020    DOI: https://doi.org/10.4143/crt.2020.203
                                     Cited By 35
    788 Comparative Effectiveness of Abdominal versus Laparoscopic Radical Hysterectomy for Cervical Cancer in the Postdissemination Era
    Jin Hee Kim, Kyungjoo Kim, Seo Jin Park, Jung-Yun Lee, Kidong Kim, Myong Cheol Lim, Jae Weon Kim
    Cancer Res Treat. 2019;51(2):788-796.   Published online September 11, 2018    DOI: https://doi.org/10.4143/crt.2018.120
                                  Supplementary         Cited By 33
    252 Tumor-Associated Macrophages Derived TGF-β‒Induced Epithelial to Mesenchymal Transition in Colorectal Cancer Cells through Smad2,3-4/Snail Signaling Pathway
    Jianhui Cai, Limin Xia, Jinlei Li, Shichang Ni, Huayu Song, Xiangbin Wu
    Cancer Res Treat. 2019;51(1):252-266.   Published online April 25, 2018    DOI: https://doi.org/10.4143/crt.2017.613
                                  Supplementary         Cited By 31
    611 Comparison of Efficacy of Pembrolizumab between Epstein-Barr Virus‒Positive and ‒Negative Relapsed or Refractory Non-Hodgkin Lymphomas
    Seok-Jin Kim, Jiyeon Hyeon, Inju Cho, Young Hyeh Ko, Won Seog Kim
    Cancer Res Treat. 2019;51(2):611-622.   Published online July 20, 2018    DOI: https://doi.org/10.4143/crt.2018.191
                                  Supplementary         Cited By 30
    502 Efficacy and Safety of Afatinib for EGFR-mutant Non-small Cell Lung Cancer, Compared with Gefitinib or Erlotinib
    Youjin Kim, Se-Hoon Lee, Jin Seok Ahn, Myung-Ju Ahn, Keunchil Park, Jong-Mu Sun
    Cancer Res Treat. 2019;51(2):502-509.   Published online June 13, 2018    DOI: https://doi.org/10.4143/crt.2018.117
                                  Supplementary         Cited By 28
    51 Magnetic Resonance-Based Texture Analysis Differentiating KRAS Mutation Status in Rectal Cancer
    Ji Eun Oh, Min Ju Kim, Joohyung Lee, Bo Yun Hur, Bun Kim, Dae Yong Kim, Ji Yeon Baek, Hee Jin Chang, Sung Chan Park, Jae Hwan Oh, Sun Ah Cho, Dae Kyung Sohn
    Cancer Res Treat. 2020;52(1):51-59.   Published online May 7, 2019    DOI: https://doi.org/10.4143/crt.2019.050
                                  Supplementary         Cited By 28
    649 Prognostic Role and Clinical Association of Tumor-Infiltrating Lymphocyte, Programmed Death Ligand-1 Expression with Neutrophil-Lymphocyte Ratio in Locally Advanced Triple-Negative Breast Cancer
    Jieun Lee, Dong-Min Kim, Ahwon Lee
    Cancer Res Treat. 2019;51(2):649-663.   Published online July 31, 2018    DOI: https://doi.org/10.4143/crt.2018.270
                                  Supplementary         Cited By 22
    194 Cancer-Associated Fibroblasts Promote the Chemo-resistance in Gastric Cancer through Secreting IL-11 Targeting JAK/STAT3/Bcl2 Pathway
    Jun Ma, Xiao Song, Xiaowu Xu, Yiping Mou
    Cancer Res Treat. 2019;51(1):194-210.   Published online April 20, 2018    DOI: https://doi.org/10.4143/crt.2018.031
                                  Supplementary         Cited By 21
    1086 Effect of Platinum-Based Chemotherapy on PD-L1 Expression on Tumor Cells in Non-small Cell Lung Cancer
    Junghoon Shin, Jin-Haeng Chung, Se Hyun Kim, Kyu Sang Lee, Koung Jin Suh, Ji Yun Lee, Ji-Won Kim, Jeong-Ok Lee, Jin-Won Kim, Yu-Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong-Seok Lee
    Cancer Res Treat. 2019;51(3):1086-1097.   Published online November 5, 2018    DOI: https://doi.org/10.4143/crt.2018.537
                                     Cited By 21
    1207 KIF11 Functions as an Oncogene and Is Associated with Poor Outcomes from Breast Cancer
    Juan Zhou, Wei-Rong Chen, Li-Chao Yang, Jun Wang, Jia-Yuan Sun, Wen-Wen Zhang, Zhen-Yu He, San-Gang Wu
    Cancer Res Treat. 2019;51(3):1207-1221.   Published online December 27, 2018    DOI: https://doi.org/10.4143/crt.2018.460
                                  Supplementary         Cited By 21
    1400 Report of the Korean Association of Lung Cancer Registry (KALC-R), 2014
    Chang-Min Choi, Ho Cheol Kim, Chi Young Jung, Deog Gon Cho, Jae Hyun Jeon, Jeong Eun Lee, Jin Seok Ahn, Seung Joon Kim, Yeongdae Kim, Yoo-Duk Choi, Yang-Gun Suh, Jung-Eun Kim, Boram Lee, Young-Joo Won, Young-Chul Kim
    Cancer Res Treat. 2019;51(4):1400-1410.   Published online February 25, 2019    DOI: https://doi.org/10.4143/crt.2018.704
                                  Supplementary         Cited By 20
    951 Acquired Resistance of MET-Amplified Non-small Cell Lung Cancer Cells to the MET Inhibitor Capmatinib
    Seulki Kim, Tae Min Kim, Dong-Wan Kim, Soyeon Kim, Miso Kim, Yong-Oon Ahn, Bhumsuk Keam, Dae Seog Heo
    Cancer Res Treat. 2019;51(3):951-962.   Published online October 10, 2018    DOI: https://doi.org/10.4143/crt.2018.052
                                  Supplementary         Cited By 19
    1033 Genetic Risk Score, Combined Lifestyle Factors and Risk of Colorectal Cancer
    Young Ae Cho, Jeonghee Lee, Jae Hwan Oh, Hee Jin Chang, Dae Kyung Sohn, Aesun Shin, Jeongseon Kim
    Cancer Res Treat. 2019;51(3):1033-1040.   Published online October 18, 2018    DOI: https://doi.org/10.4143/crt.2018.447
                                  Supplementary         Cited By 18
    510 Phase I Dose-Finding Study of OPB-111077, a Novel STAT3 Inhibitor, in Patients with Advanced Hepatocellular Carcinoma
    Changhoon Yoo, Jihoon Kang, Ho Yeong Lim, Jee Hyun Kim, Myung-Ah Lee, Kyung-Hun Lee, Tae-You Kim, Baek-Yeol Ryoo
    Cancer Res Treat. 2019;51(2):510-518.   Published online June 13, 2018    DOI: https://doi.org/10.4143/crt.2018.226
                                  Supplementary         Cited By 18
    632 Effect of Estradiol in an Azoxymethane/Dextran Sulfate Sodium-Treated Mouse Model of Colorectal Cancer: Implication for Sex Difference in Colorectal Cancer Development
    Hee Jin Son, Sung Hwa Sohn, Nayoung Kim, Ha-Na Lee, Sun Min Lee, Ryoung Hee Nam, Ji Hyun Park, Chin-Hee Song, Eun Shin, Hee Young Na, Joo Sung Kim, Dong Ho Lee, Young-Joon Surh
    Cancer Res Treat. 2019;51(2):632-648.   Published online August 1, 2018    DOI: https://doi.org/10.4143/crt.2018.060
                                  Supplementary         Cited By 18
    300 Investigating the Feasibility of Targeted Next-Generation Sequencing to Guide the Treatment of Head and Neck Squamous Cell Carcinoma
    Sun Min Lim, Sang Hee Cho, In Gyu Hwang, Jae Woo Choi, Hyun Chang, Myung-Ju Ahn, Keon Uk Park, Ji-Won Kim, Yoon Ho Ko, Hee Kyung Ahn, Byoung Chul Cho, Byung-Ho Nam, Sang Hoon Chun, Ji Hyung Hong, Jung Hye Kwon, Jong Gwon Choi, Eun Joo Kang, Tak Yun, Keun-Wook Lee, Joo-Hang Kim, Jin Soo Kim, Hyun Woo Lee, Min Kyoung Kim, Dongmin Jung, Ji Eun Kim, Bhumsuk Keam, Hwan Jung Yun, Sangwoo Kim, Hye Ryun Kim
    Cancer Res Treat. 2019;51(1):300-312.   Published online May 9, 2018    DOI: https://doi.org/10.4143/crt.2018.012
                                  Supplementary         Cited By 17
    777 A Phase II Trial of Osimertinib in the Second-Line Treatment of Non-small Cell Lung Cancer with the EGFR T790M Mutation, Detected from Circulating Tumor DNA: LiquidLung-O-Cohort 2
    Cheol-Kyu Park, Hyun-Ju Cho, Yoo-Duk Choi, In-Jae Oh, Young-Chul Kim
    Cancer Res Treat. 2019;51(2):777-787.   Published online September 7, 2018    DOI: https://doi.org/10.4143/crt.2018.387
                                  Supplementary         Cited By 17
    Korean Cancer Association
    E-Submission
    EndNote Output Style
    Email Alert
    Impact factor
    SCImago Journal & Country Rank
    PubMed Central
    MEDLINE/PubMed
    Scopus
    KoreaMed
    KoMCI
    ScienceCentral
    GoogleScholar
    Similarity Check
    Crossref Cited-by Linking
    CrossMark
    Funder Registry
    Metadata
    ORCID
    COPE
    Editorial Office
    Korean Cancer Association
    Room 1824, Gwanghwamun Officia
    92 Saemunan-ro, Jongno-gu, Seoul 03186, Korea
    TEL: +82-2-3276-2410   FAX: +82-2-792-1410   E-mail: journal@cancer.or.kr
    About |  Browse Articles |  Current Issue |  For Authors and Reviewers
    Copyright © Korean Cancer Association.                 Developed in M2PI